Key regions: United States, Japan, Australia, United Kingdom, China
The Cold & Cough Remedies market in G7 countries has been experiencing significant growth in recent years.
Customer preferences: Customers in G7 countries have shown a strong preference for over-the-counter cold and cough remedies. This is primarily due to the convenience and accessibility of these products, as well as the increasing awareness of self-care and the desire to alleviate symptoms quickly. Additionally, customers are increasingly seeking natural and herbal remedies, as they are perceived to have fewer side effects and are considered to be a more holistic approach to healthcare.
Trends in the market: One of the key trends in the Cold & Cough Remedies market in G7 countries is the growing demand for combination products. These products offer a combination of ingredients that target multiple symptoms, providing customers with a more comprehensive solution to their cold and cough symptoms. This trend is driven by the desire for convenience and simplicity, as customers prefer to purchase a single product that can address multiple symptoms.Another trend in the market is the increasing popularity of online sales channels. Customers in G7 countries are increasingly turning to online platforms to purchase cold and cough remedies. This trend is driven by the convenience of online shopping, as well as the availability of a wide range of products and competitive pricing. Online sales channels also offer customers the opportunity to read reviews and compare products, enabling them to make more informed purchasing decisions.
Local special circumstances: In the United States, the Cold & Cough Remedies market is heavily regulated by the Food and Drug Administration (FDA). This regulatory environment has led to a higher level of scrutiny and quality control in the market, ensuring that products meet strict safety and efficacy standards. In addition, the United States has a strong pharmaceutical industry, with many leading cold and cough remedy brands originating from the country.In Japan, there is a strong cultural emphasis on prevention and maintaining good health. As a result, customers in Japan are more likely to seek out cold and cough remedies at the earliest signs of symptoms, in order to prevent the condition from worsening. This has led to a higher demand for preventive products, such as immune-boosting supplements and herbal remedies.
Underlying macroeconomic factors: The growth of the Cold & Cough Remedies market in G7 countries can be attributed to several underlying macroeconomic factors. Firstly, the increasing prevalence of cold and cough symptoms, particularly during the winter months, has driven the demand for these products. Additionally, the aging population in many G7 countries has contributed to the growth of the market, as older individuals are more susceptible to cold and cough symptoms.Furthermore, the rising healthcare costs in G7 countries have led to a greater emphasis on self-care and the use of over-the-counter remedies. Customers are increasingly turning to these products as a cost-effective alternative to visiting a healthcare professional. This trend is expected to continue as healthcare costs continue to rise and customers become more proactive in managing their own health.In conclusion, the Cold & Cough Remedies market in G7 countries is experiencing significant growth due to customer preferences for over-the-counter remedies, the demand for combination products, the increasing popularity of online sales channels, and underlying macroeconomic factors such as the prevalence of cold and cough symptoms and rising healthcare costs.
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
